Search Results 551-560 of 15214 for 3-day reset protocol

1. Benzoyl peroxide (topical route) - Side effects & dosage - Mayo Clinic

   Dosing · For acne: For topical dosage form (cleansing bar):. Adults and children 12 years of age and over—Use 2 or 3 times a day, or as directed by your doctor.

2. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   Sponsor Protocol Number: 10546. About this study ... 3 (within 14 days of registration) - Platelets ... day 1. Exclusion Criteria: - Has a diagnosis ...

3. Neurology - Clinical trials - Mayo Clinic

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...

4. A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

5. Determining Lipid Content in Stool After Alpha-cyclodextrin - Mayo Clinic

   Sponsor Protocol Number: 16-005006. About this ... Consistent regular bowel movement (defined as between 3 times a day, to 1 time per day) ... 3, absolute ...

6. Clinical Trials - Digital Remote Monitoring of ICI Therapy

   ... 3 + 4 irAE or require ER visit within 100 days of registration and treatment with IPI/NIVO. This effort will allow us to refine VIGILANT as we advance its ...

7. A Study Using Docetaxel with or without MLN1117 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

   Sponsor Protocol Number: MLN1117-1501. About this ... For prior therapies with a half-life longer than 3 days ... day 1 before administration of the first dose of ...

8. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   Treatment assignments will be randomized within each Cohort. Participants who complete the study, or do not meet protocol response or remission criteria at Week ...

9. A Study of Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) - Mayo Clinic

   Sponsor Protocol Number: NIR-DT-301. About this study. The NIR-DT-301 Phase 3 ... days (or 5 half-lives, whichever is longer) prior ... days prior to first dose of ...

10. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma - Mayo Clinic

    3. Patient had a prior autologous stem cell transplant ≤ 3 months prior to first dose of study drug on Cycle 1 Day 1. 4. Patient had a prior allogeneic ...